Clinical Trials Directory

Trials / Unknown

UnknownNCT05526040

Immunonutrition Supplementation in Head and Neck Cancer Patients Undergoing Cancer Treatment Study

Head and Neck Cancer Immunonutrition Supplementation During Cancer Treatment: A Randomized, Open-label Intervention Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
116 (estimated)
Sponsor
University of Malaya · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a prospective, randomized, open-label intervention study to evaluate the effectiveness of immunonutrition supplementation in head and neck cancer (HNC) patients during cancer treatment.

Detailed description

The study population will be adult HNC patients receiving radiotherapy and chemotherapy treatment. The targeted number of subjects is 116 patients (58 subjects in each arm). Participants will be randomly assigned to receive standard medical nutrition therapy (individualized dietary assessment and counselling, and standard nutrition supplementation as necessary) or standard medical nutrition therapy with high energy, high protein, immunonutrient-enriched oral nutrition supplementation. Immunonutrition supplementation will begin 1 week prior to cancer treatment and continued throughout the cancer treatment, and to be taken in 3 servings/day. The study involves interviewing of subjects for dietary and nutrition assessment; measurement of weight, body composition, handgrip strength; and data collection from subjects' medical records.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTImmunonutrient-enriched oral nutrition supplementationIndividualized dietary assessment and counselling with additional high energy, high protein, immunonutrient-enriched oral nutrition supplement; taken 3 servings per day, from 1 week prior to cancer treatment and continued throughout the cancer treatment. Oral Impact® is an oral nutrition supplement product enriched with arginine (3.3g/sachet), omega-3 fatty acids (0.8g/sachet) and nucleotides (0.3g/sachet). The immunonutrient-enriched formula is also a complete and balanced formula, and is gluten free. The osmolality of the formula is 620 mOsm/kg water.
DIETARY_SUPPLEMENTStandard medical nutrition therapyIndividualized dietary assessment and counselling and standard nutrition supplementation via oral nutrition supplementation or enteral nutrition as necessary.

Timeline

Start date
2022-11-01
Primary completion
2023-06-30
Completion
2023-12-31
First posted
2022-09-02
Last updated
2022-09-02

Locations

2 sites across 1 country: Malaysia

Source: ClinicalTrials.gov record NCT05526040. Inclusion in this directory is not an endorsement.